Skip to content

Pathophysiological study for autoimmune dysregulation of hereditary angioedema

Pathophysiological study for autoimmune dysregulation of hereditary angioedema - Autoimmune dysregulation of hereditary angioedema

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000010754
Enrollment
50
Registered
2013-05-24
Start date
2013-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary angioedema

Interventions

Sponsors

Juntendo Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who are diagnosed hereditary angioedema.

Exclusion criteria

Exclusion criteria: nothing

Design outcomes

Primary

MeasureTime frame
We plan to compare between the results and clinical backgrouds.

Secondary

MeasureTime frame
We grope for the marker that reflect clinical severities.

Countries

Japan

Contacts

Public ContactSatoshi Mano

Complement group Division of Nephrology

manyo@juntendo.ac.jp03-5802-1065

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026